These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1398491)

  • 1. Nitric oxide and hyperdynamic circulation in portal hypertension.
    Häussinger D
    Hepatology; 1992 Oct; 16(4):1093-4. PubMed ID: 1398491
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
    Pizcueta MP; Piqué JM; Bosch J; Whittle BJ; Moncada S
    Br J Pharmacol; 1992 Jan; 105(1):184-90. PubMed ID: 1596680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats.
    Lopez-Talavera JC; Merrill WW; Groszmann RJ
    Gastroenterology; 1995 Mar; 108(3):761-7. PubMed ID: 7875478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
    Michielsen PP; Pelckmans PA
    Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of portal hypertension.
    Lebrec D; Moreau R
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):309-11. PubMed ID: 11338055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
    Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
    Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
    Wiest R; Shah V; Sessa WC; Groszmann RJ
    Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulatory hyperkinesis of cirrhosis: etiopathogenesis, clinical and therapeutic implications].
    Denie C; Henrion J
    Acta Gastroenterol Belg; 1993; 56(5-6):338-46. PubMed ID: 7511313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke.
    Shah V
    Hepatology; 2001 Nov; 34(5):1060-1. PubMed ID: 11679979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
    Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
    Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented endogenous nitric oxide production in partial portal vein-ligated rats.
    Hori N; Takahashi H; Okanoue T; Sawa Y; Mori T; Takami S; Yoshimura M; Kashima K
    Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):506-11. PubMed ID: 7586705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension.
    Sogni P; Moreau R; Gadano A; Lebrec D
    J Hepatol; 1995 Aug; 23(2):218-24. PubMed ID: 7499796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.